Experimental study on the prevention of liver cancer angiogenesis via miR-126.

Jing, B-Q; Ou, Y; Zhao, L; Xie, Q; Zhang, Y-X

Jing, B-Q; Ou, Y; Zhao, L; Xie, Q; Zhang, Y-X.

Affiliation

Jing BQ; Department of Pharmacy, Qilu Hospital of Shandong University, Jinan, Shandong, China. qilupharmacy@163.com.

Eur Rev Med Pharmacol Sci ; 21(22): 5096-5100, 2017 Nov.

Article in En | MEDLINE | ID: mdl-29228448

Subject(s)

Liver Neoplasms/pathology; MicroRNAs/metabolism; Alanine Transaminase/blood; Animals; Antagomirs/metabolism; Hep G2 Cells; Humans; Immunohistochemistry; Liver Neoplasms/blood supply; Liver Neoplasms/metabolism; Male; Mice; Mice, Nude; MicroRNAs/antagonists & inhibitors; MicroRNAs/genetics; Neovascularization, Pathologic/prevention & control; Transplantation, Heterologous; Tumor Burden; Vascular Endothelial Growth Factor A/blood; alpha-Fetoproteins/analysis

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: MicroRNAs / Liver Neoplasms Limits: Animals / Humans / Male Language: En Journal: Eur Rev Med Pharmacol Sci Journal subject: FARMACOLOGIA / TOXICOLOGIA Year: 2017 Document type: Article Affiliation country: China Country of publication: Italy

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google